Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Sep;6(9):509-14.
doi: 10.1038/nrendo.2010.125.

Phenylketonuria: a 21st century perspective

Francjan J van Spronsen  1
Affiliations
Review

Phenylketonuria: a 21st century perspective

Francjan J van Spronsen. Nat Rev Endocrinol. 2010 Sep.

Abstract

Phenylketonuria is the most prevalent inherited defect in amino acid metabolism. Owing to mutations in the gene encoding the enzyme phenylalanine hydroxylase, the essential amino acid phenylalanine cannot be hydroxylated to tyrosine and blood and tissue concentrations of phenylalanine increase. Untreated, phenylketonuria causes severe mental retardation, epilepsy and behavioral problems. The combined effect of neonatal screening and treatment has, however, meant that phenylketonuria is now a biochemical rather than a clinical diagnosis. Treatment consists of stringent dietary restriction of natural protein intake and supplementation of amino acids other than phenylalanine by a chemically manufactured protein substitute. Although clinical outcome on a phenylalanine-restricted diet is good, neuropsychological deficits are now known to exist in dietary-treated patients with phenylketonuria, and quality of life, nutritional condition and psychosocial outcome could probably also be improved. The need for new therapeutic approaches is being met by supplementation with tetrahydrobiopterin or large neutral amino acids, whilst development of the use of phenylalanine ammonia lyase, and, in the longer term, gene therapy and chaperone treatment holds promise. This Review provides an overview of the history of phenylketonuria, the challenges of treatment today and the treatment possibilities in the near future.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ann Clin Lab Sci. 1977 Mar-Apr;7(2):178-85 - PubMed
    1. Mol Genet Metab. 2010;99 Suppl 1:S68-74 - PubMed
    1. J Inherit Metab Dis. 2010 Dec;33(6):677-80 - PubMed
    1. Pediatrics. 2003 Dec;112(6 Pt 2):1575-9 - PubMed
    1. Pediatr Neurol. 2005 Oct;33(4):267-71 - PubMed